Management of Melanoma Brain Metastases (MBM)

Management of Melanoma Brain Metastases (MBM) Abstract: Melanoma is the third most common cause of brain metastases, after lung and breast cancer. Common clinical manifestations include headache, neurologic deficits, cognitive impairment and seizures. The management of melanoma brain metastases (MBM) can be broadly divided into symptom control and therapeutic strategies. Supportive treatment includes corticosteroids to reduce peritumoral edema, antiepileptics for seizure control and medications to preserve cognitive function. Until recently the therapeutic strategies focused on local treatment including surgery, whole brain radiation therapy (WBRT), and stereotactic radiation (SRS). Historically, systemic therapy has had limited utility. Immunotherapeutic drugs like anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and anti-programmed cell death protein 1 (PD1) and agents targeting BRAF- MEK pathway have revolutionized the systemic treatment of MBM. Recent clinical trials with these agents have shown activity against MBM and incre asingly being used in clinical practice. In this article, we will discuss epidemiology, biology of MBM and the role of surgery, WBRT, SRS in this patient population. An overview of the currently available systemic therapeutic agents that includes immunotherapy and targeted tyrosine kinase inhibitors (TKIs) and a practical multidisciplinary management algorithm to guide the practicing oncologist will be outlined. Introduction: Recent advances in the management of advanced melanoma have resulted in improved 5-year survival rates, however, MBM remain a significant cause of morbidity and mortality. Approximately 20% of metastatic melanoma patients have brain metastases at diagnosis.   Overall about 50% of stage IV melanoma patients will develop symptomatic brain metastases (1-3). Cerebral hemispheres are the site of 80% of brain lesions from melanoma followed by the cerebellum (15%) and brainstem (5%)(4).Common clinical manifestations include headache, neurologic deficits, cognitive impairment and seizures. Until recently, patients with MBM had a dismal prognosis with a median overall survival (OS) of 6 months (5). The management of MBM can be broadly divided into supportive management and therapeutic strategies. Supportive treatment includes steroids to reduce peritumoral edema, antiepileptics for seizure control and medications to preserve cognitive function. Traditionally, therapeutic strategies focused on local treatment including surgery, WBRT, and SRS. Historically, systemic therapy has had limited utility in the management of MBM. However, the treatment paradigm has changed considerably with the advent of targeted therapy and immunotherapy. Approximately 50% of advanced melanoma patients harbor a BRAF mutation and a number of targeted agents for this mutation and downstream pathway have shown promise in the management of metastatic melanoma. Immunotherapeutic agents like anti- CTLA-4 and anti- PD-1 have shown clinical efficacy in MBM and now constitute first line treatment options for metastatic melanoma. Biology of brain metastases: Until recently MBM were believed to have the highest mutational discordance compared to the primary site (6).   However, Chen et al. reported molecular profiling that included hot spot mutations, global mRNA expression patterns, quantitative analysis of protein expression and activation by reverse protein array (RPPA) analysis of 16 patients (7). In this study, authors reported complete concordance in mutational profile between intracranial and extracranial sites. Despite these similarities crucial differences in the expression of PI3K/AKT pathway were noted by RPPA. Another study compared the expression of BRAF mutation in different sites of metastases in advanced melanoma and showed greater mutational concordance (16/20 patients) in brain compared to other visceral/subcutaneous metastases (8). These studies provide an initial understanding of the molecular characteristics of MBM. With the advent of immunotherapy, tumor microenvironment and immune infiltration has been a focus of intense research. Brain has been traditionally thought of as an immune privileged organ but recent studies have established the existence of a neuro-immune axis and questioned this belief(9). Our understanding of this unique interplay between the immune system and central nervous system has dramatically evolved over time. Berghoff et al. investigated the expression of PD-1, PD-L1, CD3, CD8, CD45RO, forkhead box protein 3 (FoxP3), CD20, and BRAF V600E by immunohistochemistry in MBM samples (10). Varying degrees of tumor infiltrating lymphocytes (TILs) were reported in this study, 33 out of 43 specimens stained positive for CD3(+) T-lymphocytes, 39 for CD8(+) T-lymphocytes, 32 for CD45RO (+)memory T-lymphocytes, 27 for PD-1(+), 21 for FoxP3(+) T regulatory lymphocytes, and 19 for CD20(+) lymphocytes.   Significant tumoral PD-L1 expression (>5%) was observed in 9 specimens while 22 sam ples stained positive for PD-L1 suggesting role of immunotherapeutic agents in MBM. Prognostic indices Although the median OS of MBM is dismal, approximately 5% patients are long term survivors(2). Hence prognostic factors that predict outcomes and can guide the treatment decisions and enrollment in clinical trials are of value. Several large single center series have examined various primary tumor, brain metastases, and patient characteristics predictive of survival (2, 11, 12). Age, performance status, number of brain metastases, extra-cranial metastases, time from primary tumor diagnosis, presence of neurologic symptoms and elevated LDH are factors that determine survival. (13). Sperduto et al proposed a new disease basedscoring index based on 483 newly diagnosed MBM patients from 8 different centers (14). On multivariate analysis, performance status and number of BMs were prognostic for survival in MBM. The outcomes of ds-GPA MBM varied from GPA class I with survival of 3.4 months to GPA class IV with survival of 13.2 months. These prognostic indices have inherent limitations. All of them were evaluated retrospectively, had only overall survival as the end point, did not include molecular and genetic profile of the primary malignancy, and did not take systemic therapy into consideration (15). A large single institutional experience of 366 patients treated to 1,336 brain metastases has also shed some light on the interplay of important prognostic variables in patients with MBM. In this series, characteristics associated with survival included younger age, lack of extracranial metastases, performance status, and treatment with BRAF inhibitors or immunotherapies. This work specifically highlights the importance of modern out outcomes in patients who are eligible for and receive newer targeted therapies. For example, the 12-month survival estimate for patients treated with BRAF inhibitors was 37% compared to 23% for those patients who did not receive these therapies (p=0.01). Moreover, the 12-month survival e stimate for patients treated with immunotherapies was 47% compared to 22% for those patients who did not receive these therapies (p=0.04). Clearly, further work is needed to define the impact of mutation, targeted drugs and immunotherapy in the current era. Diagnosis: The neurologic symptoms associated with brain metastases include headaches, seizures, cranial nerve deficits to motor or sensory deficits. All melanoma patients with neurologic symptoms worrisome for MBM should undergo a gadolinium enhanced magnetic resonance imaging (MRI) of the brain, if no contraindications exist. Guidelines recommend routine MRI of brain with and without gadolinium contrast for patients with stage IV melanoma due to the high prevalence of asymptomatic brain metastases(16). Computed tomography of brain with and without contrast can be used as an alternate imaging. Management: The options available for management of brain metastases include surgery, WBRT, SRS, systemic therapy and symptom management. The management plan to treat these patients should take into account the overall prognosis, performance status and morbidity associated with the treatment. 5.1 Management of symptoms: Supportive care for patients with brain metastases is typically to control the cerebral edema with steroids. Due to minimalmineralocorticoid effect and long half-life, dexamethasone is the steroid of choice, however, other steroids at an equivalent dose can be used and tapered gradually over a two week period(17). A randomized trial in 1990s compared different doses of dexamethasone ranging from 4 mg/day to 16 mg/day and concluded that 4-8 mg/day would provide same degree of clinical improvement in 1 week (18). Routine use of prophylactic anti-epileptics in patients with brain metastases is not recommended(19). When patients have seizures several anti-epileptics are available including phenytoin, carbamazepine, valproic acid and levetiracetam. Non-enzyme inducing agents like levetiracetam are preferred to avoid interactions with systemic agents. 5.2 Neurosurgical Options: Surgery has traditionally been used for management of solitary brain metastases, or large symptomatic brain lesions. Multiple retrospective studies have reported improved survival with surgery compared to best supportive care(13, 20-22). Younger patients with good performance status, fairly well-controlled extracranial disease, solitary brain metastasis, lesions in accessible locations and of small size generally have better outcomes with surgery (21, 23). Surgery is usually followed by radiation boost to the surgical bed by either WBRT or SRS, with an intention of sterilizing the surrounding tissues and preventing local recurrence. Two randomized trials comparing adjuvant WBRT to surgery alone have shown improvement in outcomes(24, 25). Patchell et al. evaluated the role of WBRT post-resection of a single brain metastasis compared to surgery alone(25). Postoperative WBRT resulted in a significant reduction in local and distant intracranial failure. However, no difference in the over all survival or time duration of functional independence was noted. Similar results were seen in the EORTC 22952-26001 study with decreased 2-year intracranial and resection site recurrence without significant survival benefit. Multiple retrospective reports of post-operative SRS have shown improved patient outcomes however prospective data is awaited (26, 27). Bindal et al. showed benefit of resection in select group with multiple metastases in a retrospective review of 56 patients(28).   In practice, surgery plays an important role in debulking or removal of life-threatening lesions. Surgery also provides immediate relief from intracranial hypertension by eliminating the mass effect, and symptomatic hydrocephalus by reestablishing the flow of cerebrospinal fluid (CSF). 5.3 Whole brain radiation therapy: Melanoma brain metastases lesions are generally considered radio-resistant compared to other histologies (29). Randomized trials with WBRT have reported survival in the range of 2.4 to 4.8 months.(30) The ideal dose and number of fractions, balancing the intracranial control and cognitive decline, has been subject to intense debate.   WBRT fraction sizes of ≠¤ 3 Gy do not lead to significant neuro-cognitive decline. A retrospective study compared higher dose of radiation, 40 Gy in 20 fractions with 30 Gy in 10 fractions(31). The 40 Gy group had overall survival of 5.6 months compared to 3.1 months. However most of these trials were not melanoma specific and included patients with all tumor types. Patients who are symptomatic with change in mentation, headaches and seizures but are deemed unfit for surgery or SRS due to large number of metastases, poor performance and uncontrolled extracranial metastases are generally treated with WBRT(32). 5.4 Stereotactic radiation therapy: Stereotactic radiation has been increasingly used in the management of MBM in the last two decades. SRS in MBM results in local control rates of 50-75% at 1 year(33-35). SRS is generally limited to lesions smaller than 4 cm in diameter (36).   In a retrospective review of 333 patients treated with SRS showed a sustained tumor control rate of 73%(35). The 12-month cumulative incidence of local failure was 14% in another single institution experience of 191 patients treated to 793 MBM.   Number of brain metastases that can be treated with SRS has been intensely investigated. SRS for solitary brain metastasis was compared to surgery plus WBRT in a phase III trial that closed prematurely due to poor accrual. The overall survival, freedom from local recurrence and neurological death rates were similar in both groups(37).   Several studies have evaluated the role of SRS in patients with 1-3 brain metastases (38, 39). Aoyama et al. compared SRS alone with SRS followed by WBRT in patie nts with 1-4 brain metastases(38). No difference in neurocognitive function and survival was observed. SRS-alone arm had increased local and distant intracranial failure. A phase III trial compared WBRT followed by SRS to WBRT alone, in 333 patients with 1-3 brain metastases from different histologies that included only 13 MBM patents (40). Performance status at six months improved significantly with addition of SRS to WBRT. SRS for patients with 5-10 brain lesions was evaluated in a multi-institution prospective observational Japanese study of 1194 patients(41). The overall survival, neuro-cognitive function and post SRS complications did not differ for patients with 5-10 brain lesions compared to 2-4 brain lesions(42). 5.5 Systemic therapy: Traditional systemic therapy had a limited role in MBM due to challenges of drug delivery in the brain from blood brain barrier (BBB) with its tight junctions and efflux pumps (P-gp and MRP transport proteins) (43). The concept of localized disruption of BBB at the site of brain metastases has been proposed, as demonstrated on MRI by contrast enhancement (44). Chemotherapy: Chemotherapy agents have not shown good activity in MBM. Dacarbazine which is the approved chemotherapy for metastatic melanoma does not cross the BBB(45). A number of studies evaluated the role of alkylating agents with good BBB penetration such as temozolomide (TMZ), lomustine and fotemustine in MBM patients. In a phase II trial Agarwala et al. enrolled 151 MBM patients with no local radiation therapy for BM to receive TMZ (46). TMZ use showed a modest intracranial response of 6%, median PFS of 4.3-5.2 weeks and median OS of 3.2 months. Two phase II trials of WBRT with TMZ(47, 48); or thalidomide, WBRT with TMZ (49) failed to improve the response rates significantly. Lomustine in combination with TMZ showed modest efficacy in a phase I/II study(50).   Intracranial activity of fotemustine was first reported in a phase III trial of fotemustine versus dacarbazine for metastatic melanoma (51). This led to a randomized phase III trial that compared fotemustine plus WBRT to fotemustine alone in MBM (52). The response rates were 7.4% for fotemustine alone and 10% for fotemustine plus WBRT. Fotemustine is not currently approved by FDA for use in MBM due to delayed thrombocytopenia and leukopenia(53). Targeted therapy: BRAF, NRAS and KIT are three common, mutually exclusive driver mutations seen in metastatic melanoma (54, 55). Of these three, BRAF mutation is the most common mutation seen in approximately 40-50% of patients with advanced melanoma. The presence of BRAF, NRAS increases the risk of CNS metastases seen in patients with   advanced melanoma. Prior studies have reported 24% CNS metastases rate in BRAF and 23% CNS metastases incidence in NRAS mutant melanoma compared to 12% rate in those who lack these mutations(56). Dabrafenib and vemurafenib target BRAF V600 mutation and FDA approved for metastatic melanoma. A phase I trial of dabrafenib in ten patients with untreated asymptomatic brain metastases, intracranial response was seen in 8 patients (four CR, four PR) (57). This impressive 80% response rate prompted the phase II trial of dabrafenib in BRAF mutant melanoma brain metastases (BREAK-MB) (58). This multicenter open label study accrued 172 patients asymptomatic brain metastases with BRAFV600E or BRAFV600K mutation and one measurable lesion (defined as atleast 1 cm in diameter). Cohort A consisted of 89 patients who were radiation naive and cohort B consisted of 83 patients who had failed prior radiation therapy for BM. BRAFV600E patients had an intracranial response rate (IRR) of 39% (29/74) in cohort A and 31% (20/65) in cohort B, PFS of 16.1 weeks in cohort A and 16.6 weeks in cohort B with OS of 33.1 weeks in cohort A and 31.4 weeks in cohort B. BRAFV600K patients had a lower IRR of 7%(1/15) in cohort A and 22% (4/18) in cohort B. This trial supports the efficacy of dabrafenib in BRAF mutant MBM patients, especially those with BRAFV600E mutations with acceptable toxicity. In an open label study of 24 non-resectable, untreated MBM patients harboring BRAFV600 mutation, treatment with vemurafenib resulted in tumor regression of more than 30% (7/19)and partial response was seen in 3 patients. Median PFS and OS was 3.9 and 5.3 months respectively in this study. In a phase II study, 146 BRAF mutant MBM patients were treated with vemurafenib(59). The first cohort included 90 patients with untreated BM, the second cohort comprised of 56 patients with previously treated BM.   Complete response was noted in 2 patients, with 14 PRs, and a best objective response rate of 18%. In previously untreated MBM, the median intracranial PFS and OS were 3.7 months and 8.9 months respectively. Previously treated MBM had similar PFS and OS of 4.0 months and 9.6 months respectively. There is no prospective data of safety and efficacy of combination of BRAF inhibitors and radiation therapy. Most reports are retrospective in nature with increased incidence of dermatitis seen in extracranial skin associated with concurrent use of BRAF inhibitors and radiation (60). Rompoti et al. reported five patients with MBM treated with combined radiation and BRAF inhibitor(61). Two patients underwent SRS and three received WBRT. Patients treated with SRS did not experience any skin adverse effects while all three patients treated with WBRT noted grade1/2 dermatitis. A retrospective analysis evaluated effectiveness of vemurafenib and radiation in BRAFV600 MBM (62). All of them received vemurafenib, six patients underwent SRS, two received WBRT, one received SRS and WBRT and three underwent surgery and radiation. Thirty-six of the 48 index lesions responded with 23 (48%) CRs and 13(27%) PRs. Major limitations were the retrospective nature of the study, small number, and pretreat ed patients with radiation and systemic therapy including ipilimumab. Several small retrospective case series have reported outcomes of MBM treated with targeted agents and SRS/WBRT (Table-1). A recent study of 19 patients with BRAF mutations undergoing SRS and concurrent BRAF directed therapies has shown impressively few local failures (12-month cumulative incidence of 1%). Additional studies of combination therapy are clearly warranted. Immunotherapy: Melanoma is an immunogenic malignancy (63) with a high mutational burden that results in high number of neo-antigen(64). It has been proposed that the relatively high neo-antigen burden makes this malignancy more susceptible to immunotherapy. However, the brain has traditionally been considered an immunologically privileged site due to the presence of the BBB. Recent studies on the intracranial tumor microenvironment as elucidated above have suggested otherwise, showing CD8 T-cells, CD 20+ cells, T-regulator cells and PD-L1 expression within intracranial tumor(10). The intracranial activity of interleukin-2 (IL-2, one of the first immune modulatory agents) was reported in two retrospective reviews(65, 66).   A response rate of 5.6% was seen in 37 patients with untreated brain metastases within a larger group of 1069 metastatic melanoma and renal cell carcinoma patients treated with high dose IL-2(65). In a second report, two of the 15 brain metastases patients treated with high dose IL-2 showed CR (66). No prospective trials were initiated with high dose IL-2 due to concerns for cerebral edema and neurotoxicity. Two pathways that have revolutionized the management of advanced melanoma are those involving CTLA-4 and PD-1/PD-L1.   The CTLA-4 receptor is expressed exclusively on T-cells and downregulates the interaction between antigen presenting cells and T-cells. Ipilimumab is a fully human monoclonal antibody against the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4)(67). The pivotal phase III trial that compared ipilimumab with or without gp 100 peptide vaccine to gp 100 vaccine as a single agent allowed enrollment of patients with asymptomatic and/or previously treated MBM (68). A non-significant trend towards better survival in the MBM subgroup was noted among the patients treated with either ipilimumab alone or ipilimumab plus gp 100 compared to gp 100 alone(69). In an expanded access program (EAP) in Italy, 146 MBM patients received ipilimumab and a global response rate of 12% was seen (70). An American EAP reported a 1-year overall survival rate of 20% among 165 MBM patients tr eated with ipilimumab (71). Margolin et al. conducted an open label phase II clinical trial of ipilimumab for MBM (72). The trial enrolled 72 patients 51 patients in cohort A (those who were not on steroids for cerebral edema) and cohort B of 21 patients (on treatment with steroids). According to the WHO criteria, the response rate was 18% (9/51) in cohort A compared to 5% (1/21) in cohort B, and by immune-related response criteria the response rate was 25% (12/51) in cohort A and 10% (2/21) in cohort B. The median OS was 7.0 months and 3.7 months in cohort A and cohort B respectively. The study concluded that ipilimumab can be used safely in MBM patients. An Italian phase II trial tested a combination of ipilimumab and fotemustine in patients with advanced melanoma including asymptomatic MBM patients (73). A total of 20 patients (out of 83 patients) had asymptomatic MBM, and among these patients the study reported a PFS of 3.0 months and 3-year OS rate of 27.8% (74). A randomized, 3 arm, phase III trial of fotemustine, versus fotemustine plus ipilimumab, versus ipilimumab plus nivolumab (NIBIT-M2) is currently recruiting patients (75). Several retrospective studies have evaluated the safety of combining ipilimumab and radiation therapy (SRS or WBRT), and prospective trial data is forthcoming (76-78). PD-1 receptors are expressed on several cells including T-cells and antigen presenting cells. Their interaction with PD-L1 ligands on tumor cells leads to T-cell exhaustion and downregulation of tumor-specific immune response(79). Nivolumab and pembrolizumab are two anti-PD-1 antibodies that are currently approved for the management of advanced melanoma, and several others are under evaluation. An open label, single-center, phase II clinical trial is currently enrolling patients with untreated brain metastases from melanoma or non-small cell lung cancer (80). In a published early analysis, a response rate of 22% (4 patients) was reported in a total of 18 MBM patients and the responses were durable. Authors noted a high concordance between systemic and brain metastasis responses. Additionally, 11% (2 patients) had stable disease. Intriguingly all responders lacked a BRAF mutation. Relatedly, 4 patients were not evaluable either due to rapid progression necessitating BRAF-targeted ther apy (3 patients), or intralesional hemorrhage (1 patient). Toxicities in the MBM cohort included grade 3 transaminitis (1 patient), as well as grade 1-2 seizures (3 patients) and grade 3 cognitive dysfunction (1 patient) from peritumoral edema. Leptomeningeal disease in melanoma   Leptomeningeal disease (LMD) is a subset of metastatic with extraordinarily poor prognosis and median survival of 8 weeks(81, 82). About 5% of malignant LMD originates from melanoma (Kesari) and up to 23% of melanoma cases develop LMD(1, 83). Primary leptomeningeal melanoma also exists as a separate clinical entity and should be a consideration in the context of a person with multiple congenital melanocytic nevi(84). Diagnosis of LMD is usually made based on the combination of neurologic symptoms along with corresponding leptomeningeal enhancement on MRI. While cytology from cerebrospinal fluid (CSF) is considered to be the gold standard for LMD diagnosis, sensitivity of this testing ranges from 50% to 80%, depending on number of lumbar punctures performed (85). Like with MBM, treatment of LMD with chemotherapy has low response rates(86). The clinical course of LMD is more treacherous in melanoma in other malignancies given the propensity for melanoma LMD to hemorrhage(87). Molec ular characterization of melanoma LMD suggests a higher percentage of BRAF mutations in comparison to the general melanoma population (68% v 45%), based on a single center melanoma LMD cohort of 60 patients(76). Several case reports have been published highlighting complete and partial responses as well as prolonged ongoing survival beyond 15-18 months with BRAF inhibitors (86). Immunotherapy approaches, including intrathecal IL-2, adoptive cell therapies with tumor infiltrating lymphocytes (TILs) and cytotoxic T-lymphocytes (CTLs), and immune checkpoint inhibitors, have also reported prolonged survival in comparison to historic medians (86). A single center study of 38 patients with melanoma LMD who were treated with intrathecal IL-2 reported a median survival of 9.1 months, and the best 15% of patients reached a median survival over 24 months(88). Ongoing survival over 18 months in a melanoma LMD case was reported with WBRT followed by ipilimumab, an immune checkpoint CTLA-4 inhib itor; in this case, treatment with ipililumab resulted in complete radiologic response(89). A phase II trial of combination immunotherapy with ipilimumab and nivolumab, a PD-1 inhibitor, in melanoma LMD has recently opened to accrual(90). In summary, these early data suggest that both targeted therapy and immunotherapy have efficacy in melanoma LMD and can result in durable responses well over a year. Upcoming trials addressing melanoma LMD with newer therapies will likely yield significantly improved survival data over the next decade. Conclusion: Despite significant recent improvement in the outcomes of patients with melanoma, brain metastases remain a major determinant of mortality and morbidity in melanoma patients, and patients with MBM remain in the worst prognostic category. The vast majority of clinical trials with newer agents exclude patients with MBM, thus data on the effectiveness of new drugs in the context of MBM is still lacking. Understanding the biology of MBM and its clinical response to newer agent and particularly combinations of agents and strategies is crucial to increasing the longevity of the poorest-risk melanoma. Appropriate care of MBM begins with diagnosis. In melanoma, the brain is a common site of metastatic spread, both early and late. It is crucial to begin screening patients for MBM at diagnosis, and NCCN guidelines have recently been updated to reflect this changing diagnostic paradigm. The frequency at which to repeat imaging is still not known. Several therapeutic options now exist for the treatment of MBM (A proposed algorithm is provided in Figure-1). Surgical resection, radiation therapy, targeted therapy and immunotherapy all show some degree of efficacy with MBM.   Even in cases of LMD, perhaps the worst subset of MBM in terms of survival, treatment with targeted therapy and immunotherapy can induce prolonged survivals from historic means. Initial reports involving combinations of these therapies, such as radiotherapy with either targeted therapy or immunotherapy, appear promising, but will need to be systematically studied in cohorts with larger numbers. Equally important will be the parallel investigation of predictive markers in MBM with these therapies and combinations. Thus, whenever possible, patients with a new diagnosis of brain metastases should be enrolled in appropriate clinical trials. If an appropriate clinical trial is unavailable, treatment decisions should be made with input from a multidisciplinary t eam including radiation oncologists, neurosurgeons, and medical oncologists.

My Broter my executioner Essay

When Luis returned to Sipnget for vacation after being unable to visit for years because of studying and then now because of work he visited his grandfather and his mother, but originally he decided to go back to visit his ailing father, Don Vicente. He planned to stay for weeks even for a month but then he suddenly changed his mind when he realized that the place had already changed a lot, his brother is not there and more over his mother and grand father has gone believing that his father and all the rich people should give up their wealth to the poor. He couldn’t take it. And, also there was the Hukbalahap which is against the Japanese and the elite’s— he couldn’t take it anymore. Before leaving first thing in the morning the next day he heard his father shout in surprise and when he ran to look after him he saw the window glass of his father’s room was broken and a stone wrapped in paper was on the floor, when his father picked it up and then read the message it says that â€Å"he should give all he has to those who deserves it better— the poor.† Luis, stunned by what he saw was also wondering who did it. He kept thinking but only one suspect is fitted with the situation. It’s his brother Victor who is very best at using sling—sling was the best thing to use to throw a stone trough the mansion’s security. After that, Luis fled off back to manila and then there was a time that Victor came to him and asks for his support—just the same as to the message his father got, back to Sipnget. What is the conflict of the story? Thus, the brothers had different personalities, beliefs, views and status in life. They met again as both friends and foes. These are their misunderstandings as brothers. Luis considers himself liberal. He is against the goals of his brother which is to put down his status as a wealthy landowner for the benefit of the poor. What is the climax of the story? He returned to Rosales. He came home together with Trining, his female cousin, who studies in the convent. In order for the Asperris to preserve their wealth, Luis married Trining. After sometime, she got pregnant. But in manila, Luis also had an affair with his manager’s daughter – Ester – which is also Trining’s best friend. But because they quarreled one night, Ester disappeared and was found out to be dead. He then found out from his mother that his half-brother Victor became the commander of Hukbalahap (hukbong bayan laban sa mga hapon) which is against rich people and feudal landowners. What is the resolution? At the end of the story, Vic warned them about the Huks. He told him to leave the place. But they didn’t listen. Trining got shot and died. Luis then revenged and fought for his status and for the death of his wife. VI.REACTION TO THE NOVEL This story is a must read for everyone for it elaborates on the political structures and some aspects of the Philippine history. It is also somewhat similar to Jose Rizal’s Noli me Tangere and el Filibusterismo. Reading it really requires full attention for them to be able to grasp the meaning of the story. Although the theme tackles more on political life of the rural people, readers can still be caught by romance in some chapters, particularly to Luis, and his affection for 2 women, Trining and Ester. When Trining died I felt sorry for both the main character and her. As said Luis took revenge for his status and his wife so that settles it because I definitely like to have my revenge if it was me. Good for Luis he is elite so he didn’t feel so down and he had the power to do so. I was surprised to read the incest situation in the novel I couldn’t bring myself to believe but the writer simply made it as if it was real. I fell thinking, are there many incest here in our country just to preserve their pure elite blood? I felt being more understanding to respect everyone’s choices for they have their own motives. My understanding of people’s motives has now been clear to me that everything has a cause and that cause might be good or bad but still we follow what we believe because we are humans we can decide for our own. While reading I found some Filipino values depicted in the novel and they we’re: the true love and respect of family members. Patience, dignity, disciplines and being responsible—they were all shown with great passion. From what I now observe in our system as Filipinos we must keep deep understanding between the poor and the rich. Now we have this border that keeps our world apart that sparks a revolution against each other. We must learn to understand, listen and share. VII.BIOGRAPHY OF THE AUTHOR F. Sionil Josà © or in full Francisco Sionil Josà © (born December 3, 1924) is one of the most widely-read Filipino writers in the English language. His novels and short stories depict the social underpinnings of class struggles and colonialism in Filipino society. Josà ©Ã¢â‚¬â„¢s works – written in English – have been translated into 22 languages, including Korean, Indonesian, Russian, Latvaian, Ukrainian, Dutch. Childhood Josà © was born in Rosales, Pangasinan, the setting of many of his stories. He spent his childhood in Barrio Cabugawan, Rosales, where he first began to write. Jose was of Ilocano descent whose family had migrated to Pangasinan before his birth. Fleeing poverty, his forefathers traveled from Ilocos towards Cagayan Valley through the Santa Fe Trail. Like many migrant families, they brought their lifetime possessions with them, including uprooted molave posts of their old houses and their alsong, a stone mortar for pounding rice. Life as a writer Josà © attended the University of Santo Tomas after World War II, but dropped out and plunged into writing and journalism in Manila. In subsequent years, he edited various literary and journalistic publications, started a publishing house, and founded the Philippine branch of PEN, an international organization for writers. Josà © received numerous awards for his work. The Pretenders is his most popular novel, which is the story of one man’s alienation from his poor background and the decadence of his wife’s wealthy family. Throughout his career, Josà ©Ã¢â‚¬â„¢s writings espouse social justice and change to better the lives of average Filipino families. He is one of the most critically acclaimed Filipino authors internationally, although much underrated in his own country because of his authentic Filipino English and his anti-elite views. Sionil Josà © also owns Solidaridad Bookshop, which is on Padre Faura Street in Ermita, Manila. The bookshop offers mostly hard-to-find books and Filipiniana reading materials. It is said to be one of the favorite haunts of many local writers. Works Rosales Saga novels A five-novel series that spans three centuries of Philippine history, widely read around the world and translated into 22 languages * Po-on (Dusk) (English, 1984) * The Pretenders (1962) * My Brother, My Executioner (1973) * Mass (December 31, 1974) * Tree (1978) Original novels containing the Rosales Saga * Dusk (Po-on) (1993) * Don Vicente (1980) – Tree and My Brother, My Executioner combined in one book * The Samsons Other novels * Gagamba (The Spider Man) (1991) * Viajero (1993) * Sin (1994) * Ben Singkol (2001) * Ermita * Vibora! (2007) * Sherds (2008) Short story collection * The God Stealer and Other Short Stories (2001) * Puppy Love and Other Short Stories (March 15, 1998) * Olvidon and Other Stories (1988) * Platinum: Ten Filipino Stories (1983) (now out of print, its stories are added to the new version of Olvidon and Other Stories) * Waywaya: Eleven Filipino Short Stories (1980) * Asian PEN Anthology (as editor) (1966) * Short Story International (SSI): Tales by the World’s Great Contemporary Writers (Unabridged, Volume 13, Number 75) (co-author, 1989) Children’s books †¢ The Molave and The Orchid (November 2004) Verses * Questions (1988) Essays and non-fiction * In Search of the Word (De La Salle University Press, March 15, 1998) * We Filipinos: Our Moral Malaise, Our Heroic Heritage * Soba, Senbei and Shibuya: A Memoir of Post-War Japan * Heroes in the Attic, Termites in the Sala: Why We are Poor (2005) * This I Believe: Gleanings from a Life in Literature (2006) * Literature and Liberation (co-author) (1988) In translation * Po-on (Tagalog language, De La Salle University Press, 1998) * Anochecer (Littera) (Spanish language, Maeva, October 2003) In anthologies * Tong (a short story from Brown River, White Ocean: An Anthology of Twentieth-Century Philippine Literature in English by Luis Francia, Rutgers University Press, August 1993 In film documentaries * Francisco Sionil Josà © – A Filipino Odyssey by Art Makosinski, 1996 Awards * Ramon Magsaysay Memorial Awards for Journalism, Literature and Creative Communication Arts (1980) * National Artist Award for Literature (2001)[8] * Pablo Neruda Centennial Award (2004) * Palanca Awards

Online Forms Of Communications, Like Social Media

Online forms of communications, like social media, have undoubtedly provided convenient methods to communicate with anyone at any moment. Adolescents have been reported to spend on average six hours consuming media (Wallace). The point when an unhealthy amount of time is spent on social media is when negative social risks can begin to present themselves—children and adolescents, who are experience significant brain growth and development, are the most at risk for social damage. Heidi, a thirteen-year-old girl previously described as a happy, sweet, and loving girl, screams â€Å"I’m going to kill you while you are both asleep† as she flails and kicks her father before biting his arm. This was Heidi’s second violent rage in a week because her parents took away her access to social media; this would also be the second time that she would be taken to a psychiatric emergency room (Kardaras). Heidi is one adolescent who has crossed the line of healthy social me dia usage and now has moved towards risks likes anxiety and depression, social media dependency, and inadequate social skills. Social media can negatively affect mental health causing by an overall decline in mental health, anxiety, and depression—adolescents who use media the most among their peers report being overall less content and are often unhappy(Carroll). On social media sites like Facebook, people can choose what version or parts of themselves they can show to people—so most people may choose to show the best parts.Show MoreRelatedHow Social Media Affects Our Lives1158 Words   |  5 PagesEverywhere, everyone, all the time, all around, people are on social media. Look anywhere, an adult can be found scrolling through social media, teenagers especially, and even the elderly can be found on some form of social media. Whether it is a status on Facebook, a  ¨selfie ¨ on Instagram, a tweet on Twitter, or a video on Snapchat, everyone connects through social media to improve their relationships. This simple form of online communication has affected everyone ´s relationships for the better. WhichRead MoreEssay on How Does Facebook and Twitter Affect Social Interaction1257 Words   |  6 Pagesfingertips. With the evolution of communications technology, methods of political participation and civic engagement have also changed to adapt to this advance made by mankind. Before, our choice was limited to holding demonstrations, going out to the streets, and protesting in order for our voices to be heard. Consequently, we had no choice but to resort to lobbying and writing letters to politicians for our concerns to be known. In the present time, communication among people has been made easierRead MoreThe Effects Of Social Media On Society1328 Words   |  6 PagesSocial Media â€Å"Those that interact via social media on a daily basis are five times likelier to use tobacco, three times likelier to use alcohol, and twice as likely to use marijuana† (Stein). â€Å"It is important that parents evaluate the sites on which their child wishes to participate to be sure that the site is appropriate for that child’s age† (O keeffe, Clarke-Pearson). Parents and guardians of teens worry about what they do on the internet, while at the same time, the parents aren’t doing theirRead MoreSocial Media And Its Impact On Today s World Essay1234 Words   |  5 Pagesin today’s world, so does the use of social media. Social media, as defined by Merriam-Webster is, â€Å"forms of electronic communication through which users create online communities to share information, ideas, personal messages, and other content.† That definition is what will be implied from now forward. Social media and its growing popularity, especially among th e younger generations, has lead to difficulties with socialization skills. Although social media may come with other benefits, this sideRead MoreThe Effects Of Social Media On Our Lives1608 Words   |  7 Pagesbeginning, face-to-face communication has been an important factor in our lives. This was the only source of communication for a long period of time. Over time, we developed new ways of communicating with each other such as emailing and talking on the phone. Human beings have become so reliant on the use of electronic devices to communicate. Although this is a good way to keep in touch with friends, it can become a serious problem to many individuals. The growth of social media sites began to grow inRead MoreThe Use Of Social Media On Society831 Words   |  4 PagesAdvancements in electronic communication have produced a multitude of new platforms in which people can connect to one another. These developments have torn down the geographic barriers previously separating peo ple and their ideas, making it easier and faster to connect with others and thus creating a new sense of community. Online communities where people can share their interests with like-minded people have been appearing rapidly and have revealed a new community that would have otherwise beenRead MoreSocial Media Has Affected The Way Human Interact With Each1402 Words   |  6 PagesSocial media has affected the way human interact with each other. Social media is websites and applications that enable users to create and share content or to participate in social networking, which involves Facebook, Twitter, Instagram, and Snapchat. Adolescents use social media to make relationships that are really interment, but could be dangerous. Most adolescents do not interact with one another in person as much they use to before social media. Adolescents would rather video chat and messageRead MoreImpact Of Social Media On Business Essay1288 Words   |  6 Pages2014 reflects a drastic change in the direction of social media. Now, more than ever, consumers are wary of businesses and advertisements. As a result, the trust falls to a third party – a brand or person who is not affiliated with the company receiving the promotion. What does that mean for your business? Businesses are encouraged to become their consumers’ friends, chatting about a product or something related, in a manner that is non-threatening, and even enjoyable. The most effective way forRead MoreImpact Of Social Media On Communication827 Words   |  4 PagesImpact of Social Media on Communication Topic: Impact of social media on communication General Purpose: to inform Specific Purpose: to inform audience on how social media has changed the way we communicate with others Thesis: Social media has impacted the way we as a society use communication in our daily lives as well as in our business relationships. I. Introduction: a. Attention getter: You’re sitting at home bored and you don’t know what to do so you text your best friend to hang out. OrRead MoreSocial Media And Its Effect On Society1644 Words   |  7 PagesIn today’s day in age almost everyone has some form of social media. Many people have more than one. Whether it is Facebook, Twitter or some other form. We all use it to express and communicate our thoughts and feelings about ourselves and the world. Because of this many people do not know how to communicate face to face anymore and many times even hide behind their keyboard. Keller (2013), Quotes Paul Booth an assistant professor of media and cinema studies saying â€Å"There has been a shift in the

Depression in Teens - 1459 Words

Throughout the world, people are struggling daily with one, if not multiple, mental illness. Some of these individuals have been diagnosed as a result of symptoms they exhibit, while others struggle in silence. For those that have received help, life slowly looks brighter for them, while loved ones work to help in any way possible. One of the serious mental illnesses that teens struggle with is depression. There are various aspects as to why an adolescent may develop depression including social, academic, or family problems, as well as stress or past issues; however, if others recognize the warning signs, complications can be avoided and treatment obtained to overcome depression. Depression â€Å"extends beyond sadness to the point of illness†¦show more content†¦In addition, he is apt to start abusing substances or have a change in eating patterns (Goldenberg). All in all, if one has depression, many emotional changes will occur, eventually causing physical changes which m ay be viewed as warning signs. Due to depression, one may develop various other complications that will affect his lifestyle. These could include difficulty in school, violent behaviors, low self-esteem, addictions to drugs, alcohol, smoking, pornography, or the internet, as well as the potential of becoming a runaway (Smith, Barston, and Segal). In addition, one suffering from depression is more likely to have an early pregnancy, develop an eating disorder, other mental health disorders, harm himself, or even become suicidal, which is the third leading cause for death of teens (â€Å"Teen Depression†). Overall, if depression is not diagnosed and goes untreated, there is a high risk that the person suffering from depression will develop other problems in his life. As a result of emotional changes, warning signs, and complications developed from the illness, a teen may be taken to a doctor or other professional to determine whether he is depressed. Depression can be â€Å"determined by professionals by conducting psychological tests on a teen, as well as conducting interviews with the teen, his family, and his friends†Show MoreRelatedTeen Depression In Teens1284 Words   |  6 PagesAlex Leon Mrs. Kim Roberts English IV 21 October 2017 Depression in Teens Depression is a mental disorder or an mental illness that impacts people all around the world. In America, it has grown tremendously since 1980 and has been affecting younger and younger people, it was once only affecting adults but in recent years has been getting to adolescents and children. Most recently more than 10 percent of adolescents develop a depressive disorder before the age of 18(Collins, 2017). In this paperRead MoreTeen Depression1523 Words   |  7 PagesIntroduction The research project my group and I decided to do was on teen depression. We wanted teens to be more familiar with this major teen issue and how it affects our daily lives. Teen depression is a major concern and it is not fully acknowledged within high schools. Many people even adults don’t understand the results of teen depression. The statistics on teen depression are sobering. Studies indicate that one in five children have some sort of mental, behavioral, or emotional problemRead MoreTeen Depression3489 Words   |  14 Pagesresponsibility and days filled with fun, laughter and joy. This reality is a fairytale for some teenagers. Adolescent depression is a real and growing problem in our society. Numbers of depression diagnosed in adolescents are on the rise. Is this because of more depressed teenagers, or is there an explanation for this. Are there underlying problems or causes for the high depression numbers? Is there something that we can do to help these teenager s. What are the symptoms and diagnoses. Factors contributingRead MoreTeenage Depression And Teen Depression792 Words   |  4 Pages Teen depression, which is also known as adolescent depression, is a growing problem in today’s society. Depression among teenagers is overlooked by many and is often mistaken for â€Å"normal† teenage behavior. This mental illness is one of the most common psychiatric disorders. Depression is predominantly seen amongst young women who are transitioning into adulthood. Teenagers are at a point in their lives where they come face to face with the reality of peer pressure and a milestone in becomingRead MoreTeen Depression : Teenage Depression1477 Words   |  6 Pages Teenage Depression Depression has a major impact on the lives of teenagers; And through analysis it says that teen girls have a higher risk at suffering depression. Depression grows more and more everyday in today s society. While researching more about depression realized that teenage girls are at a higher risk for depression. Depression is an common and serious medical illness that negatively affectsRead MoreTeen Depression : The Problem Of Teenage Depression, And Teen Suicide721 Words   |  3 PagesTeen depression is a definite topic most people are unaware of and depression is a worldwide issue and is the leading disability. Depression can lead to many things, from anxiety to thoughts of suicide. Things like social media is a big cause of depression. Everyone has those days where they are feeling sad or maybe even just having a bad day. Sometimes, it goes even more downhill. When it turns into something major, it becomes a real problem. Some p eople ignore the issue, brushing it off as a â€Å"phaseRead MoreTeen Depression Essay749 Words   |  3 Pages Teen depression ultimately impacts this society generation . Recognizing the signs and diagnostics that could prevent teenagers with this mental illness. , Be aware there are several different types of depression . Teens from one or more types. Teenage depression is becoming a problem in today’s society. However, Depression, it’s a mood disorder that causes persistent feelings of sadness and lost of interest also called clinical depression it affects how you feel , thinkRead MoreEssay on Teen Depression1653 Words   |  7 PagesClinical depression is capable of ruining the future. In a few years, teenagers will be moving up in the world and beginning their lives as contributing members of society. Each one of them will have a job, and will encounter countless other individuals. The dilemma that the world faces is about 17% of teenagers will suffer from depression before they become adults (Canada). This impacts connections not only in the political/business world, but their personal lives and growth as well. TeenageRead MoreDepression And Its Effects On Teens1268 Words   |  6 Pagesuntreated, even a lifetime. An estimated 350 million people of all ages suffer from depression. Of these affected, one in eight teens suffer from this disease (World Health Organ ization, para. 1). Depression is an attenuating disease, affecting teens at an increasing rate, and it is essential for one to know what teenage depression is, how depression affects teenagers and what can be done to prevent it. Depression in teens is a mental health condition that causes a continuous feeling of sadness overRead MoreTeen Depression Essay910 Words   |  4 PagesDepression is the most widespread mental illness in today’s society. Studies have found that, 1 out of 8 teens are affected with this disease. It also predominantly affects young ladies than it does males. (www.kidshealth.org). Teens are at a position in their lives when they must face significant transition and peer pressures. They are trying to identify with themselves and trying to figure out where there puzzle piece fits in society, all of which can show the way to behavioral and emotional changes